InvestorsHub Logo

DewDiligence

03/18/17 10:59 AM

#147 RE: BuckeyeMike #146

ESPR was the hardest-hit company yesterday in the fallout from AMGN's Repatha-CVOT presentation:

#msg-129644330

How do you explain that?